Medical Aspects of Chemical Warfare (2008) - The Black Vault

Indexassignment of specific emergency support functions, 755FEMA. See Federal Emergency Management AgencyFentanyldescription and incapacitating effects, 419summary of BZ and fentanyl derivatives (exhibit), 429use by Russia in the Chechen hostage situation, 3, 65, 107, 413,419Fetal bovine serum AChEbioscavenging use, 245, 246Fidder, A.blood sample analysis for mustard agent (figure), 723lewisite exposure research, 728organophosphorus compound research, 699urine sample analysis for mustard agent, 711, 713Field management of chemical casualties. See also Treatment ofincapacitating agent exposure; Treatment of mustard agentexposure; Treatment of nerve agent exposure; Treatment of toxicindustrial chemical exposureattack measures, 494–495“buddies” and, 486casualty decontamination (figure), 502casualty number and agent characteristics and, 496civilian perspective, 492–493cold zone, 500, 506comparison of military battlefield and civilian casualty careand decontamination (table), 501comparison of taxonomy of care capabilities with levels (echelons)of care particular to chemical casualty management(table), 488–489core principles, 486decontamination area, 505decontamination equipment, 497decontamination levels, 500detailed example of the layout of a patient decontaminationsite (figure), 504early control point and arrival area, 503–504evacuation corridor, 500force health protection description, 486hazardous materials (HAZMAT) response teams and, 492–493hazardous waste operations and emergency response trainingand, 515HAZMAT incident medical treatment site setup (figure), 503health service support description, 486hot line, 505hot zone, 498–499, 501integration of military support into civilian homeland response,493–494key objectives, 495land-based forces, 487–491local responses, 492–493medical equipment and supplies needed, 497–498medical management process, 494–506military management concepts in the civilian setting, 500–502minimal decontamination procedures based on agent characteristics(table), 498National Incident Management System, 492National Response Plan, 492national site setup and control zones for a hazardous materialssite (figure), 515patient processing, 502–506personnel requirements, 495–497pillars of force health protection (figure), 487postattack, or recovery, measures, 495preattack measures, 494rapid and effective response capability, 486sea-based forces, 491–492service-specific operations, 487–492taxonomy of care capabilities (figure), 490terrorist attack capabilities, 493–494triage and treatment area (cold zone), 506triage area (warm side), 504–505vapor control line, 505warm zone, 499–500, 504–505wet-bulb globe temperature and, 495–496work-rest cycles and water consumption (without protectiveensemble) (table), 497work-rest cycles for workers, 495–496, 542worker fitness level and, 496–497zones of contamination, 498–500, 543Field Management of Chemical Casualties Handbookmustard agent treatment, 670Filbert, M.G.dexanabinol research, 229Fisher, PFC David Allenexposure to mustard agent during the Persian Gulf War(exhibit), 107Fiske, Maj. Norman E.Italian-Ethiopian War observation report, 45520th Theater Army Medical Laboratoryfield-forward assays for chemical agent exposure, 693Floridaparalytic shellfish poisoning and, 624Flumazenilincapacitating effects, 420Fluoxetineincapacitating effects, 421Foch, Marshal FerdinandChampagne-Marne defensive and, 30Meuse-Argonne campaign and, 33Ford, Pres. Geraldincapacitating agent use and, 443Foroutan, Syed Abbaschemical agent exposure in children and, 656nerve agent and mustard agent treatment research, 184,195–196patient thorough decontamination research, 540, 547Foulkes, Maj. Gen. Charles H.effectiveness of gas as a weapon, 794-dimethylaminophenolcyanide poisoning treatment, 395–3964-DMAP. See 4-dimethylaminophenolFrance. See also specific battles and battle sitesBerber war, 42–43chemical warfare use during World War I, 12–21cyanide use during World War I, 373hydroxocobalamin treatment for cyanide poisoning, 396, 676incapacitating agent use, 443weaponizing of phosgene, 341Franco-Prussian Warcyanide use, 373Frandsen, A.dantrolene research, 228Franzblau, A.2-chlorobenzylidene malononitrile research, 452Free radical scavengersneuroprotectant use, 232French, M.C.dibenz[b,f]-1,4-oxazepine research, 467Fricke,cyanide poisoning treatment, 396Fries, Maj. Gen. Amos A.chemical training for soldiers and, 104Chemical Warfare Service and, 43–44Gas Service command, 22, 89–90xxxix